EyePoint Pharmaceuticals Inc (EYPT)
8.99
-0.01
(-0.11%)
USD |
NASDAQ |
Nov 27, 15:38
EyePoint Pharmaceuticals Shares Outstanding: 68.25M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 68.25M |
September 30, 2024 | 53.52M |
August 02, 2024 | 53.52M |
June 30, 2024 | 52.16M |
May 02, 2024 | 52.08M |
April 23, 2024 | 52.08M |
March 31, 2024 | 49.89M |
March 01, 2024 | 49.83M |
December 31, 2023 | 49.04M |
December 08, 2023 | 48.84M |
October 27, 2023 | 35.31M |
October 17, 2023 | 35.31M |
September 30, 2023 | 35.31M |
July 28, 2023 | 34.98M |
June 30, 2023 | 34.31M |
April 27, 2023 | 34.30M |
April 21, 2023 | 34.30M |
March 31, 2023 | 34.30M |
March 02, 2023 | 34.30M |
December 31, 2022 | 34.08M |
November 01, 2022 | 34.08M |
September 30, 2022 | 34.07M |
September 23, 2022 | 34.07M |
August 01, 2022 | 34.07M |
June 30, 2022 | 34.05M |
Date | Value |
---|---|
April 29, 2022 | 34.05M |
April 25, 2022 | 34.05M |
March 31, 2022 | 34.05M |
March 04, 2022 | 34.04M |
December 31, 2021 | 33.91M |
November 19, 2021 | 33.89M |
October 29, 2021 | 28.77M |
September 30, 2021 | 28.77M |
August 05, 2021 | 28.77M |
July 30, 2021 | 28.77M |
June 30, 2021 | 28.75M |
April 30, 2021 | 28.74M |
April 26, 2021 | 28.74M |
March 31, 2021 | 28.74M |
March 05, 2021 | 28.74M |
February 04, 2021 | 28.68M |
February 01, 2021 | 18.19M |
January 14, 2021 | 18.16M |
December 31, 2020 | 18.14M |
December 30, 2020 | 15.13M |
December 09, 2020 | 15.13M |
December 08, 2020 | 15.13M |
October 30, 2020 | 14.35M |
October 15, 2020 | 13.32M |
September 30, 2020 | 13.14M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
10.94M
Minimum
Dec 31 2019
68.25M
Maximum
Oct 31 2024
30.30M
Average
33.91M
Median
Dec 31 2021
Shares Outstanding Benchmarks
Cassava Sciences Inc | 48.11M |
Regeneron Pharmaceuticals Inc | 109.89M |
Adverum Biotechnologies Inc | 20.80M |
Regenxbio Inc | 49.55M |
Editas Medicine Inc | 82.55M |